These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8523878)

  • 1. Differential diagnosis of thymic carcinoma and lung carcinoma with the use of antibodies to cytokeratins.
    Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Niwa H; Kiriyama M; Eimoto T
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1670-5. PubMed ID: 8523878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratins in normal thymus and thymic epithelial tumors.
    Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
    Cancer; 1993 Jan; 71(1):99-105. PubMed ID: 7677978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
    Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
    Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma.
    Hayashi A; Fumon T; Miki Y; Sato H; Yoshino T; Takahashi K
    J Clin Exp Hematop; 2013; 53(1):9-19. PubMed ID: 23801129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary thymic carcinoma: a clinicopathological and immunohistochemical study.
    Shimizu J; Hayashi Y; Morita K; Arano Y; Yoshida M; Oda M; Murakami S; Watanabe Y; Nonomura A
    J Surg Oncol; 1994 Jul; 56(3):159-64. PubMed ID: 7518018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.
    Su XY; Wang WY; Li JN; Liao DY; Wu WL; Li GD
    Int J Clin Exp Pathol; 2015; 8(5):5354-62. PubMed ID: 26191237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistological analysis of thymoma by molecules differentially expressed in the thymic cortex and medulla, and its application in the differential diagnosis of thymoma from esophageal and lung cancer.
    Shiraishi J; Utsuyama M; Akashi T; Nemoto T; Ohashi K; Akamatsu H; Sunamori M; Kitagawa M; Hirokawa K
    Pathol Res Pract; 2001; 197(9):611-9. PubMed ID: 11569925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.
    Nakagawa K; Matsuno Y; Kunitoh H; Maeshima A; Asamura H; Tsuchiya R
    Chest; 2005 Jul; 128(1):140-4. PubMed ID: 16002927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary carcinomas of the thymus gland.
    Ritter JH; Wick MR
    Semin Diagn Pathol; 1999 Feb; 16(1):18-31. PubMed ID: 10355651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.
    Nonaka D; Henley JD; Chiriboga L; Yee H
    Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathyroid epithelial thymoma (ITET) and carcinoma showing thymus-like differentiation (CASTLE): CD5-positive neoplasms mimicking squamous cell carcinoma of the thyroid.
    Kakudo K; Bai Y; Ozaki T; Homma K; Ito Y; Miyauchi A
    Histol Histopathol; 2013 May; 28(5):543-56. PubMed ID: 23233417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratins of normal epithelia and some neoplasms of the female genital tract.
    Moll R; Levy R; Czernobilsky B; Hohlweg-Majert P; Dallenbach-Hellweg G; Franke WW
    Lab Invest; 1983 Nov; 49(5):599-610. PubMed ID: 6195450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: a large scale study of 1465 non-small cell lung cancer cases.
    Kriegsmann M; Muley T; Harms A; Tavernar L; Goldmann T; Dienemann H; Herpel E; Warth A
    Diagn Pathol; 2015 Dec; 10():210. PubMed ID: 26643918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall.
    Adam P; Hakroush S; Hofmann I; Reidenbach S; Marx A; Ströbel P
    Virchows Arch; 2014 Sep; 465(3):313-20. PubMed ID: 24923897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratins and lung carcinomas.
    Nhung NV; Mirejovský P; Mirejovský T; Melínová L
    Cesk Patol; 1999 Jul; 35(3):80-4. PubMed ID: 11038661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms.
    Pomplun S; Wotherspoon AC; Shah G; Goldstraw P; Ladas G; Nicholson AG
    Histopathology; 2002 Feb; 40(2):152-8. PubMed ID: 11952859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pattern of intermediate filaments in thymomas].
    Dirsch OR; Odermatt BF; Scherrer C; Heitz PU
    Verh Dtsch Ges Pathol; 1990; 74():424-8. PubMed ID: 1708630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratins in normal lung and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines.
    Blobel GA; Moll R; Franke WW; Vogt-Moykopf I
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 45(4):407-29. PubMed ID: 6203212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.
    Ramaekers F; van Niekerk C; Poels L; Schaafsma E; Huijsmans A; Robben H; Schaart G; Vooijs P
    Am J Pathol; 1990 Mar; 136(3):641-55. PubMed ID: 1690512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thymic carcinomas].
    Ströbel P; Weis CA; Marx A
    Pathologe; 2016 Sep; 37(5):425-33. PubMed ID: 27538748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.